Will I have to take medication for life
GLP-1 RAs were identified in the DRUG files using generic or brand names, including exenatide (BYETTA, BYDUREON BCISE), liraglutide (VICTOZA, SAXENDA, XULTOPHY), lixisenatide (LYXUMIA, ADLYXIN, SOLIQUA), dulaglutide (TRULICITY), semaglutide (OZEMPIC, RYBELSUS, WEGOVY), and tirzepatide (MOUNJARO, ZEPBOUND)
Composition of Acetyl L-Carnitine Acetyl-L-carnitine, Vegetable cellulose capsule, Bulking agent: cellulose, Anti-caking agent: Silica dioxide, Rice hull concentrate
CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027
Lifestyle changes, like building a healthier diet and moving more, play an important role in weight loss at this stage of treatment
Q: Can I combine different peptides